ARID1A

ARID1A Full Name

AT rich interactive domain 1A (SWI-like)

ARID1A Introduction

AT-Rich Interaction Domain 1A (ARID1A) is a highly conserved chromatin remodeling protein and core subunit of the SWI/SNF (BAF) ATP-dependent chromatin remodeling complex, functioning as a master epigenetic regulator of gene transcription, cell cycle control, and tissue homeostasis in mammalian cells. Encoded by the ARID1A gene located on human chromosome 1p36.11, this nuclear protein is ubiquitously expressed across most human tissues, with critical functional activity in epithelial tissues, stem cells, and rapidly renewing cell populations. As a key DNA-binding component of the SWI/SNF complex, ARID1A specifically recognizes AT-rich genomic sequences, modulates nucleosome positioning, and alters chromatin accessibility to activate or repress downstream target gene transcription. It governs a wide spectrum of fundamental biological processes, including embryonic development, cell differentiation, DNA damage repair, and immune homeostasis. Extensive clinical and molecular studies confirm that ARID1A is a prominent tumor suppressor gene in humans. Frequent mutational inactivation, downregulated expression, or functional deficiency of ARID1A is closely associated with developmental defects, inflammatory disorders, and the initiation and progression of multiple malignant tumors, making ARID1A a core epigenetic regulatory gene and a high-value clinical diagnostic and prognostic biomarker.

Figure 1. Schematic structure of ARID1A.

Core Physiological Functions of ARID1A
ARID1A executes indispensable physiological epigenetic functions to maintain developmental stability, cellular homeostasis, and tissue integrity throughout human organ systems. During embryonic and tissue development, ARID1A-driven chromatin remodeling precisely regulates stem cell self-renewal and lineage-specific differentiation, controlling organ morphogenesis, epithelial tissue maturation, and normal tissue patterning. In mature somatic cells, ARID1A acts as a critical cell cycle checkpoint regulator, suppressing abnormal cell overproliferation and maintaining orderly cell cycle progression to prevent aberrant cellular growth. Moreover, ARID1A participates in fundamental DNA damage response and genome stability maintenance; it facilitates chromatin relaxation at DNA lesion sites, promotes efficient DNA repair, and reduces genomic mutation accumulation. ARID1A also modulates cellular senescence, apoptosis, and metabolic gene expression, balancing cell survival and tissue renewal. In epithelial barrier tissues, ARID1A preserves normal tissue architecture and cellular polarity, supporting long-term tissue physiological stability and organ homeostasis under normal conditions.

strong>Immune and Inflammatory Regulatory Roles of ARID1A
ARID1A serves as a vital epigenetic modulator linking chromatin remodeling with immune homeostasis and inflammatory response regulation. Physiological ARID1A expression negatively regulates excessive inflammatory activation by epigenetically repressing the transcription of multiple pro-inflammatory cytokines and chemokines, limiting aberrant NF-κB and MAPK pathway activation in epithelial and immune cells. ARID1A deficiency significantly enhances inflammatory transcriptional programs, promoting persistent pro-inflammatory microenvironment formation, immune cell infiltration, and chronic tissue inflammation. In tumor microenvironments, ARID1A loss induces robust immune reprogramming, upregulating immunosuppressive molecules, recruiting regulatory T cells and tumor-associated macrophages, and facilitating tumor immune escape. This immune-modulatory function enables ARID1A to bridge epigenetic dysfunction, chronic inflammation, and tumor immune tolerance, playing a pivotal role in inflammatory disease progression and cancer immunotherapy response.

Alternate Names for ARID1A

ARID1A; AT rich interactive domain 1A (SWI-like); ELD; B120; OSA1; P270; hELD; BM029; MRD14; hOSA1